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ABSTRACT The molecular basis of anesthetic interaction with membrane proteins has been explored via determination of
anesthetic effects on the structure and dynamics of the extended second transmembrane domain (TM2e) of the human
neuronal nicotinic acetylcholine receptor (nAChR) b2 subunit in dodecylphosphocholine (DPC) micelles by
1H and 15N solution-
state NMR. Both 1-chloro-1,2,2-triﬂuorocyclobutane (F3) and isoﬂurane, two volatile general anesthetics, induced nonuniform
changes in chemical shifts among residues in TM2e. Saturation transfer difference NMR experiments further conﬁrmed the
direct anesthetic interaction with TM2e. A signiﬁcant and more speciﬁc anesthetic interaction was observed on three leucine
residues at the helix C-terminus. Although the TM2e helical structure remained after addition of anesthetics, plausible
shortening and lengthening of helix hydrogen bonds were evidenced by periodic changes in backbone amide chemical shifts.
The TM2e backbone dynamics were determined on the basis of the 15N relaxation rate constants, R1 and R2, and the
15N-[1H]
NOE using the model-free approach. The global tumbling time (11.7 ns) of TM2e in micelles slightly increased (;12.3–12.5 ns)
in the presence of anesthetics. The order parameter, S2, exceeded 0.9 for all 15N-labeled residues, showing a restricted internal
motion. Anesthetics appear to have minor effect on the TM2e’s internal motion. This study provided the basis for subsequent
more comprehensive studies of anesthetic effects on the transmembrane domain complex of neuronal nAChR.
INTRODUCTION
The molecular mechanism of general anesthesia remains an
enigma. After more than a century of clinical practice, no one
knows with certainty how high-order functions of the central
nervous system can be disrupted reversibly by general
anesthetic molecules. The obstacle for a comprehensive
understanding lies in the complexity of the central nervous
system and the lack of powerful tools that allow us to
straightforwardly find answers to this unsolved mystery.
Nicotinic acetylcholine receptors (nAChRs) (1,2), along
with other members in the superfamily of cys-loop receptors
(3), have been identified as potential targets of general
anesthetics (4,5). They are pentameric channel proteins respon-
sible for the fast synaptic transmission in the central and pe-
ripheral nervous systems. Each of five subunits of a receptor
comprises an extracellular domain, four transmembrane do-
mains, an intracellular domain, and loops that link these domains.
The second transmembrane domain (TM2) of each subunit
lines the pore of a channel. Site-directed mutagenesis within
the TM2 domain showed markedly changed sensitivity of
nAChR to anesthetics, indicating possible anesthetic-sensitive
sites in the TM2 (6–8). The 19F nuclear magnetic resonance
study of anesthetic isoflurane binding to nAChR reconstituted
in phospholipid bilayers suggested no more than two specific
binding sites in each subunit of nAChR and a nonspecific
interaction with the lipid phase (9). Anesthetic halothane
direct photoaffinity labeling of the Torpedo nAChR in native
membranes demonstrated multiple similar binding domains
for halothane in the transmembrane region of the nAChR
(10). Halothane photolabeling of residue Tyr-228 in the
d-subunit of Torpedo nAChR was later identified (11). More
recently, a photoactivatable analog of the intravenous general
anesthetic etomidate was found to label several residues in
a- and d-subunits of Torpedo nAChR in a state-dependent
and subunit-selective fashion (12). These studies provided
valuable information for potential anesthetic binding sites in
nAChR. However, further investigation is necessary to prove
whether findings on Torpedo nAChR can be generalized for
other types of nAChR, considering that many potential
anesthetic binding sites suggested by photolabelingwere highly
subunit dependent. Moreover, to gain insights into how
anesthetics alter the protein functions, we need to know not
only anesthetic binding sites but also the structural and dynamic
consequences of nAChR in response to the anesthetic inter-
action.
The structure determination of an intact receptor protein,
such as nAChR, has proven extremely difficult. The currently
available structure model for Torpedo nAChR, obtained
using cryo-EM with 4 A˚ resolution (13,14), is invaluable to
serve as a structure template for other members in the cys-
loop receptor family, although there are still unsolved
segments and loops in the structure. The high-resolution
structures of intact neuronal nAChRs that are more sensitive
than Torpedo nAChR to volatile general anesthetics have not
been experimentally determined yet, and these determina-
tions are unlikely to be resolved any time soon because of the
tremendous technique challenges. A more realistic approach
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is a systematic reduction-rebuild approach. An excellent
demonstration of this approach is the study of the 3-D
structure of the G-protein-coupled receptor rhodopsin (15).
Using the same approach, we obtained high-resolution
structures of transmembrane domains of neuronal nAChR
b2 subunit on the basis of NMR experiments (16,17), which
provided the structural basis for characterizing anesthetic
interaction with neuronal nAChRs. It is worth mentioning
that neuronal nAChRs containing b2 subunits are particularly
sensitive to volatile general anesthetics (7,18,19).
In our study, we determined effects of two volatile general
anesthetics, isoflurane and 1-chloro-1,2,2-trifluorocyclobu-
tane (F3), on the structure and backbone dynamics of a
peptide segment corresponding to the extended TM2 domain
of the human neuronal nAChR b2 subunit (TM2e). The
atomistic resolution of NMR spectra allows us to identify
residues interacting with anesthetics and to determine the
structure and dynamics consequences of the TM2e on the
anesthetic interaction. The knowledge gained from this study
laid the ground for further investigation of general anesthetic
effects on multidomain complex targets.
MATERIALS AND METHODS
Sample preparation
The extended TM2 domain (TM2e) of the human neuronal nAChR b2
subunit, including residues EKMTLCISVLLALTVFLLLISKIVPPTS (mo-
lecular mass of 3.05 kDa), was obtained by solid-phase synthesis as
described previously elsewhere (16,17). All seven leucine residues were
selectively 15N labeled. For reconstitution of the TM2e peptide into DPC
micelles, TM2e dissolved in trifluoroethanol (Sigma, St. Louis, MO) was
added to an aqueous solution of DPC (Avanti Polar Lipids, Alabaster, AL) to
reach desired surfactant/peptide molar ratios. Typically, there are 1–3 mM
TM2e and 100–450 mM DPC in the sample. The samples were lyophilized
after vigorous mixing and rehydrated with 10% D2O for deuterium lock
in NMR measurements. Two samples of 50 mM DPC in 90% H2O and
10% D2O were prepared as control for
1H saturation transfer difference
(STD) experiments. DPC-d38 and D2O were obtained from Cambridge
Isotope Laboratories (Andover, MA). Volatile anesthetics isoflurane (Abbott
Laboratories, North Chicago, IL) and F3 (PCR, Gainesville, FL), shown
in Fig. 1, were added directly to the NMR samples using a gas-tight
microsyringe.
NMR spectroscopy
The majority of NMR spectra were recorded at 30C on a Bruker Avance-
600 NMR spectrometer (1H: 600.03MHz; 15N: 60.81 MHz) equipped with a
triple-resonance inverse-detection cryoprobe, TCI (Bruker Instruments,
Billerica, MA). The TM2e chemicals shift assignment was accomplished
previously (16) using 1H TOCSY and NOESY experiments as well as 15N-
filtered NOESY experiments. Fluorinated anesthetics added to the samples
were quantified by 19F NMR on a Chemagnetics CMX-400SLI spectrometer
(19F: 377.37 MHz; Otsuka Electronics, Fort Collins, CO) using aqueous
solutions of trifluoroacetic acid as external references for the chemical shift
and concentration. 15N-decoupled 1H homonuclear two-dimensional nuclear
Overhauser effect (NOE) spectroscopy (NOESY) data were typically
acquired at 600.03 MHz into 2048 t2 and 640 t1 data points with a spectral
width of 10 ppm in each dimension, 72 to 80 transients per increment, and
100-ms mixing time. The WATERGATE pulse scheme (20) was applied for
water suppression. The States-TPPI method was used for quadrature
detection in the indirect dimension (21). Gradient-selected sensitivity-
enhanced 1H-15N heteronuclear single quantum correlation (HSQC) data
were typically acquired into 2048 t2 and 80 t1 data points, with spectral width
of 12–14 ppm for 1H and 15 ppm for 15N. To confirm anesthetic interaction
with TM2e, 1H STD experiments (22) were performed on samples
containing 10 mM isoflurane or 13 mM F3 in the presence and absence of
TM2e on a Bruker Avance-800 MHz spectrometer. Water suppression was
achieved using excitation sculpting with gradients (23). TM2e signals were
not filtered. A STD spectrum was obtained by subtracting a pair of spectra
(DI ¼ Ioff  Ion) acquired in an interleaved fashion with on- and off-
resonance frequencies of 0.6 ppm and 15 ppm, respectively. A series of STD
spectra were collected with a low saturation power of 20 Hz at different
saturation times, including 1, 2, 4, 7, and 10 s. Each STD spectrum was a
sum of 256 scans. The recycle delay of 20 s was found adequate for 1H
relaxation and used in the experiment. Spin-lattice (R1) and spin-spin (R2)
15N relaxation rate constants, and 15N-[1H] NOE values were repeatedly
measured at 600.03 MHz for each of the 15N amides using standard pulse
sequences (24) with echo-antiecho gradient selection (25,26). Typically, 80
t1 data points were used with recycle delays of 2.3 s or 1.8 s for R1 and R2
measurements, respectively. There were nine variable delays ranging from
20 to 1800 ms for R1, and 17 to 170 ms for R2. In NOE experiments, 80
indirect data points were acquired with or without proton saturation in
interleaved fashion. Saturation was achieved by a train of 120 pulses at
5-ms intervals for duration of 3 s. 1H chemical shifts were referenced to the
2,2-dimethyl-2-silapentane-5-sulfonate (DSS) resonance at 0 ppm, and 15N
chemical shifts were referenced indirectly (27).
Data processing and analysis
All NMR spectra were processed using NMRPipe and NMRDraw (28) with
a linear prediction or zero filled to double or quadruple data points in each
spectral dimension and analyzed using Sparky (29). The NOE on anesthetics
from TM2e was calculated by (Ioff  Ion)/Ioff, where Ioff and Ion are the
anesthetic peak intensities in STD spectra acquired off and on resonance of
TM2e, respectively. NOE errors were derived from spectral signal/noise
ratios (24). The 1H and 15N chemical shift changes of TM2e induced by
anesthetics were obtained by subtracting individual peak frequencies in a
pair of NMR spectra acquired without and with anesthetics. Typically each
processed HSQC spectrum had 4096 3 512 data points, giving an
uncertainty of 0.004 or 0.03 ppm for the 1H and 15N frequency readings. 15N
R1 and R2 values were determined from two-parameter fits of peak intensities
versus variable delay to single exponential functions. 15N-[1H] NOE values
were reported as peak intensity ratios obtained with and without 1H
saturation. The global tumbling time (tm) was initially estimated from the
R2/R1 ratio (30) and refined by fitting experimentally measured R1, R2, and
NOE values in the framework of Lipari-Szabo formalism (31,32) and
subsequent Monte Carlo numerical simulations using the Modelfree
software package (33,34) or using the Tensor-2.0 program (35). All the
models in the ‘‘Modelfree’’ package were tested for model selection. Our R1,
R2, and NOE data were best described using the model that included the
squared order parameter (S2) but excluded the exchange rate constant and the
effective correlation time for fast internal motions. Therefore, this model was
chosen for final relaxation data analysis.
FIGURE 1 Chemical structures of the volatile anesthetics (A) F3 and (B)
isoflurane.
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RESULTS
Direct interaction of isoflurane or F3 with TM2e was
confirmed by the STD experiments. Fig. 2 A displayed
representative STD spectra at selected saturation times for
TM2e with 10 mM isoflurane and 13 mM F3. Peak
intensities (DI) of isoflurane and F3 in the STD spectra
resulted from a pair of spectra, acquired in an interleaved
fashion, with the saturation frequency off and on resonance
of TM2e (DI ¼ DIoff  DIon). If anesthetics had no direct
contact with proteins, their nuclear magnetization would not
be affected by saturating protein magnetization, and then
anesthetic signals would be canceled in a STD spectrum
(DI ¼ 0). If anesthetics interacted with proteins, longer
saturation time would lead to more magnetization transfer
until it reached a steady state. Apparently, both isoflurane
and F3 had close contact with TM2e. Fig. 2 B illustrated the
relative amount (DI/DIoff) of magnetization transferred to
isoflurane or F3 from TM2e at different saturation times. The
same STD experiments were repeated under the same sample
conditions but without TM2e (see Fig. 1S in Supplementary
Materials). No anesthetic signals were detected in STD
spectra (Fig. 1S, A9 and B9), confirming that the observed
isoflurane and F3 signals in the presence of TM2e indeed
result predominately from direct anesthetic interactions with
TM2e.
The presence of F3 or isoflurane perturbed the 1H and 15N
chemical shifts of TM2e in DPC micelles. As revealed from
1H-15N-HSQC spectra in Fig. 3, both anesthetics induced up-
field (such as L5) and low-field (L19) shifts. The peak
displacement was inhomogeneous along the TM2e sequence.
Of all the leucine amides, L5 is most sensitive to both
anesthetics. The differences in the patterns of HSQC chemical
shift changes on addition of F3 and isoflurane are minor, but
isoflurane has noticeably greater effects on L11 than F3. L19
ismore sensitive to F3 than to isoflurane. The dependencies of
the leucine peak displacements on the anesthetic concentra-
tions are demonstrated in Fig. 4. The overall magnitude of
anesthetic effect is presented using the weighted average of
the 15N and 1H chemical shifts of selected amide groups,
defined as DdHN ¼ ½ðDd2H1Dd2N=25Þ=2½ (36). The changes
in chemical shifts increase linearly with the elevation of
anesthetic concentrations in a certain range. It is worth
mentioning that chemical shifts of all leucine residues, except
L5, became insensitive to additional amounts of anesthetics
when anesthetic concentration went beyond a few millimolar
in range (Fig. 2S).
Anesthetic effects on the TM2e structure were determined
by measuring the anesthetic-induced 1Ha and
1HN shifts for
all residues of TM2e through 1H NOESY NMR spectra. As
demonstrated in Fig. 5 A, variations of Ha chemical shifts
FIGURE 2 (A) Saturation transfer difference (STD) spectra of 1 mM
TM2e in 50 mM of DPC micelles at marked saturation times in the presence
of 10 mM isoflurane (left) and 13 mM F3 (right). (B) NOE on isoflurane
(h) and F3 (d) as a function of the saturation time. NOE was measured by
(Ioff  Ion)/Ioff, and NOE uncertainties were determined by the signal
intensity and noise level. Notice the NOE steady-state regime at longer
saturation times.
FIGURE 3 Overlay of 1H-15N HSQC NMR spectra of 1.0 mM TM2e
(15N-labeled leucine) in 150 mMDPC in the absence (black) and presence of
14 mM F3 (red) or 11 mM isoflurane (green).
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induced by the addition of anesthetics were generally small.
The secondary chemical shift index based on deviations of
Ha proton chemical shifts from their random coil values (37)
in the absence and presence of anesthetics showed the value
of 1 for most of the TM2e residues, suggesting that
anesthetics did not significantly modify the TM2e secondary
structure (16). The secondary shifts of the amide protons
(HN) are more sensitive to anesthetics than Ha. Fig. 5 B
showed that F3 induced changes in the HN chemical shift
along the TM2e sequence, where the positive and negative
change represented HN down- and up-field shift relative to
the resonances without anesthetics, respectively. The peri-
odicity of HN chemical shifts along a protein sequence could
be observed from helical proteins and was interpreted mainly
resulting from a shortening of hydrogen bonds (HBs) on the
hydrophobic side of helices and a lengthening of HBs on the
hydrophilic side (38). A weak periodicity in the change of
the HN chemical shift occurred after the addition of
anesthetics (Fig. 5 B). Although it is impossible to quantify
HB changes solely based on the HN chemical shift changes,
such a periodic change suggested the possibility of subtle
shortening or lengthening of HBs on different sides of TM2e
and a certain degree of helical curvature induced by
anesthetics, as depicted in Fig. 6.
The anesthetic effects on the backbone dynamics of TM2e
were determined by 15N relaxation of seven selectively 15N-
FIGURE 4 Changes in (A) 1H and (B) 15N chemical shifts of amide NH of 2
mM TM2e in 100 mM of DPC micelles are modulated by anesthetic F3 (solid
symbols) and isoflurane (open symbols). (C) The complex change in chemical
shifts, DdHN, was calculated using DdHN ¼ ððDd2H1ðDd2N=25ÞÞ=2Þ1=2. The
symbols for eachLeu are:n, L5;d, L10;:, L11;;, L13;¤, L17;<, L18;=,
L19. Data were obtained from 15N-HSQC NMR spectra in the absence and
presence of various concentrations of F3 or isoflurane. The solid lines resulted
from the least-squares fitting of the changes in leucine chemical shift induced by
varying F3 concentrations.
FIGURE 5 Anesthetic F3 induced changes in (A) 1Ha and (B)
1HN
chemical shifts of 1.0 mMTM2e in 150 mM of DPC-d38 micelles. Data were
obtained from NOESY spectra in the absence and presence of ;20 mM F3.
FIGURE 6 Molecular surface representation of the TM2e structure in
DPC micelles delineating a sensitivity of different residues along the TM2e
chain to anesthetic F3 using the magnitude and direction of F3-induced
amide proton shifts (Fig. 4 B) as criteria. The residues having lengthened or
shortened HBs are labeled and covered with cyan and yellow surface,
respectively. Leu 5 is also colored in cyan. The gray lines highlight putative
membrane surfaces. The TM2e structure in DPC was calculated as described
elsewhere (16).
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labeled leucine residues. As summarized in Fig. 7, addition of
either anesthetic (F3 or isoflurane) resulted in a downward
trend inR1 and an upward trend inR2 formost of leucines. The
trend became even more apparent when the amount of
anesthetic reached more than 10 molcules per DPC micelle
(see Fig. 3S). The opposite trends of R1 and R2 change
indicate a slower global tumbling of the micelle-bound
TM2e. Indeed, the R2/R1 ratio for those residues whose
relaxation is not affected by the fast internal motions on the
picosecond time scale is virtually independent of the internal
motion and provides an initial estimation for the reorientation
time of each NH vector with global tumbling, i.e., the tm of
the peptide (30). The tm of TM2e in DPC, obtained from the
R2/R1 ratio and averaged over all leucine residues except L5,
yielded 11.7 ns in the absence of anesthetics and 12.5 and
12.3 ns in the presence of 13 mM F3 or 9 mM isoflurane,
respectively. The NOE values were elevated slightly in
residues L5 and L19 but slightly lower or unchanged in other
leucine residues after addition of anesthetics. The square
order parameter S2, as shown in Fig. 7D, was derived later by
further analysis of the NMR relaxation data using a model-
free approach (31,32). The values of S2 are greater than 0.9 for
all leucine residues, with or without anesthetics, indicating
that all leucines are located in regions with restricted internal
motions.
DISCUSSION
The STD experiments provided lines of evidence that both
isoflurane and F3 directly interact with TM2e. However, the
NOEs on anesthetic molecules from TM2e are small in
comparison to those found from several globular proteins (39)
but in a good agreement with what is observed in anesthetic
interaction with transmembrane channel peptides (40).
Smaller NOE on anesthetics in membrane proteins would
be expected for at least two reasons. First, a large portion of
anesthetics in membrane proteins interacted with lipids
because of their good solubility in lipids (41,42). Second, it
was shown that the on and off rates of isoflurane interacting
with the nAChRwere an order ofmagnitude higher than those
with the globular protein BSA (9). The shorter life of
anesthetic-protein complexes would lead to lower NOE
values. The lock-and-key-type interaction, mostly found for
ligand binding in enzymatic proteins, may not be a proper
description for anesthetic interaction with channel proteins
that are more relevant as anesthetic targets.
The STD experiments offered the answer to whether
anesthetics directly interacted with TM2e. Chemical shift
perturbation by anesthetics offered the clue for which part of
TM2e anesthetics interacted with. One may not be able to
rule out a possibility that anesthetic disturbed micelle
structure and consequently altered TM2e conformation and
changed the TM2e chemical shift. However, the confirmed
direct anesthetic interaction with TM2e must have made
dominant contributions to the TM2e chemical shift changes.
Both isoflurane and F3 perturbed the chemical shift of L5
(locating it closer to the micelle periphery) to a similar
extent, but isoflurane had a stronger effect than F3 on
leucines closer to the TM2e center, such as L11. This may be
related to the different geometric shapes of two anesthetics
(Fig. 1): isoflurane is a linear molecule that can reach the
TM2e residues more remote from its primary interaction site,
whereas smaller and more compact F3 lacks this ability.
Among all leucine residues in TM2e, L5 showed a unique
reaction to the addition of anesthetics. At a low concentration
of anesthetics, L5 had the most significant chemical shift
changes (Fig. 4). At higher concentrations of anesthetics
(Fig. 2S), other residues became insensitive to additional
anesthetics, but the L5 chemical shift changed steadily in
response to increased anesthetic concentration. The unique-
ness of L5 resulted from its special location in the TM2e
structure and micelles. Our previous study (16) ascertained
that L5 was located at the edge of the TM2e helix in the most
labile water-micelle interface, whereas the other six leucines
have more stable patterns of hydrogen bonding, as evidenced
by their high degree of protection from amide exchange. It
was suggested by our early studies (40,42,44,45) that
preferred partition in the amphipathic region of a membrane
FIGURE 7 Relaxation rate constants R1 (A) and R2 (B),
15N-[1H] NOE
values (C), and squared order parameters S2 (D) for leucine amides of TM2e
in DPC micelles in the absence of anesthetics (squares) and in the presence
of 13 mM F3 (circles) and 9 mM isoflurane (triangles) at 30C. The molar
ratio of TM2e to DPC was 2:100. Errors were derived from the statistical
dispersion and either from the uncertainties of the least-squares fit to the
exponential decay function (for R1 and R2) or from the signal/noise ratios
(for NOE). Error bars for S2 (D) are standard deviations derived from 300
Monte Carlo simulations.
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to its hydrophobic core was a characteristic of volatile
general anesthetics related to their anesthetic activity.
Therefore, the observed unique interaction between anes-
thetics and L5 confirms that the micelle-water interface is a
place where anesthetics are distributed preferentially. Be-
sides L5, L17, L18, L19, and I20 constitute a cluster of
anesthetic-sensitive residues at the C-terminus of the TM2e
helix, corresponding to the extracellular site of nAChR (Fig.
6). Similar locations of anesthetic sites near the C-terminus
of TM2 have been pinpointed for the a and d subunits of the
muscle nAChR in photolabeling studies (12).
It is interesting to note that F3 had a minute effect on Ha
but significantly affected the TM2e HN (Fig. 5). The Ha
chemical shifts are known to be sensitive to the secondary
structures of proteins, and their differences from the random
coil values are often used in protein secondary structure
predictions (37,38). Insensitivity of Ha chemical shifts to
anesthetics implied a well-preserved TM2e secondary
structure in the presence of anesthetics. This is in accord
with our previous finding on gramicidin, an ion channel
peptide (44,45). Although anesthetics used for this study did
not change the TM2e secondary structure, perturbation of the
helix HBs seemed to be real. The up-field and down-field
shifts of amide protons are often taken as evidence of
lengthening or shortening of the corresponding HBs (46).
Chemical shift oscillations for the amide protons in the
middle region of TM2e occurred in a quasiperiodic fashion
with the apparent periodicity of three or four residues (Fig.
5 B). The predicted pore-lining residues (T4, S8, L11, and
V15) appear to be much less affected by anesthetics. Several
residues adjacent to the pore-lining residues at either side
seemed to be affected more. Such a pattern of hydrogen bond
distortion across the peptide caused by nonsymmetric
anesthetic interactions with the TM2e might also occur in
the intact nAChR. The perturbation to the helical hydrogen
bonding in the pore-lining domain, TM2, may generate
impact to the channel properties, although it is hard to
quantify such impact at present. Whether the subtle changes
in the pore-lining domain will ultimately modify channel
functions needs to be further investigated.
The correlation time tm for global tumbling of TM2e in
DPC increased after addition of anesthetics to the sample,
especially at a high anesthetic concentration. The diffusion of
the TM2e-micelle complexwas best described by an isotropic
diffusion tensor both in the presence and absence of
anesthetics. Without anesthetics, the tm value corresponded
to the tumbling of the whole complex including the TM2e, a
DPC micelle, and a hydration layer (;0.5 ns/kDa for
isotropic tumbling according to the Stokes-Einstein model).
The size of the complex became larger after addition of
anesthetics. The tm rising from 11.7 to 12.3 ns in the absence
and presence of isoflurane, respectively, could be ascribed
primarily to the association of about five isoflurane molecules
to the complex (estimated using the Stokes-Einstein model).
Other conceivable mechanisms for the anesthetic-induced
increase in tm could be through introduction of some degree
of anisotropy in global tumbling or reduction of the peptide
motion relative to the micelle (47,48). Because there was no
strong indication of TM2e internal motion on the nanosecond
timescale (16), it seemed unlikely that interdependence of
internal and global motion contributed to the tm increase. The
robustness of order parameters to anesthetics implied a
minute anesthetic effect on the TM2e flexibility. The
anesthetic molecules in the TM2e-micelle-anesthetic com-
plex interacted not only with TM2e but also with DPC
micelles. If associated anesthetics altered themicelle structure
drastically so that the TM2e conformation and TM2e
association with micelles were largely affected, it would be
reflected in the TM2e backbone dynamics. The subtle change
in tm and stable order parameters of the TM2e backbone do
not support this possibility. The lack of evidence for
significant changes in TM2e backbone dynamics could be
caused by the timescale mismatching between TM2e back-
bone motion and NMR measurements. If the anesthetic-
induced changes in TM2e internal dynamics occurred on a
timescale different from pico- to nanoseconds, it would be
undetectable by the conventional model-free analysis. Our
attempts to search for TM2e internal motion on a micro- to
millisecond timescale found no indication of such motion.
Nevertheless, TM2e is only one of the four transmembrane
domains in nAChR. The limited anesthetic effect on internal
motion of the TM2e might be amplified once this pore-lining
domain is integrated with other transmembrane domains.
Indeed, we observed substantial anesthetic modulation on
micro- to millisecond timescale motions of a four-helical
bundle protein (T. Cui et al., article in review). Other previous
studies also provided experimental evidence of anesthetic-
induced changes in protein dynamics. Halothane and isoflu-
rane decreased the mobility of the indole rings in BSA and
stabilized BSA to thermal denaturation, as studied by fluo-
rescence anisotropy and circular dichroism (49) as well as
differential scanning microcalorimetry (50). Bromoform
binding in the firefly luciferase crystal structure was shown
to cause a neighboring histidine residue (H-310) to become
less mobile (51). In addition, computational studies eluci-
dated the potential importance of anesthetic modulation on
protein dynamics (52). The global anesthetic effects on func-
tional relevant motions of firefly luciferase have been re-
vealed recently via Gaussian and anisotropic network
analysis (53). Nevertheless, it is important to explore further
the anesthetic effects on protein dynamics that ultimately
affect protein functions. Research along this line on whole
transmembrane domains of nAChR are in progress in our
laboratory.
CONCLUSIONS
Taken together, we conclude that there is direct anesthetic
interaction with the TM2e, especially at the helix N- and
C-termini, which are situated at the micelle-water interface,
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namely, in the vicinity of L5 and in the L17–L19 region. The
‘‘saturatable’’ nature of the chemical shifts of C-terminal
L17–L19 region at elevated anesthetic concentrations marks
the region with specific anesthetic interactions. In contrast,
the anesthetic interaction with the N-terminal L5 seems less
specific, as evidenced by the ‘‘unsaturatable’’ nature of L5
chemical shift at relatively high anesthetic concentrations.
Although the presence of anesthetics did not significantly
alter the TM2e secondary structure, the perturbation of the
helix hydrogen bonding was implicated by a periodic change
in the TM2e HN chemical shifts. Preferable lengthening of
HBs on one side and shortening on another side of the helix
might induce a certain degree of helix bending. The anes-
thetic interaction had little impact on the TM2e backbone
dynamics. Although the findings on a single TM2e domain
are valuable, a study of anesthetic effects on the complete
transmembrane domain and beyond is essential to gain more
comprehensive insights into the anesthetic modulation of
nAChR structure and dynamics and, ultimately, of nAChR
functions (54).
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